Slides
Page 1
Big Technologies plc 2026 Hal f Ye ar Resu lts I n v es t o r P re s e n t a t i o n S e p t e m b e r 2026
Page 2
Disclaimer Neither this presentation nor any verbal communication shall constitute, or form part of, any offer, invitation or inducement to any person to underwrite, subscribe for , or otherwise acquire or dispose of, any shares or other securities in Big Technologies plc (“Big”). Forward-looking statements This presentation and information communicated verbally to you may contain certain projections and other forward-looking statements with respect to the financial condition, results of operations, businesses and prospects of Big. The use of terms such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “estimate”, “intend”, “continue”, “target” or “believe” and similar expressions (or the negatives thereof) are generally intended to identify forward-looking statements. These statements are based on current expectations and involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward- looking statements. Any of the assumptions underlying these forward-looking statements could prove inaccurate or incorrect and therefore any results contemplated in the forward-looking statements may not actually be achieved. Nothing contained in this presentation or communicated verbally should be construed as a profit forecast or profit estimate. Investors or other recipients are cautioned not to place undue reliance on any forward-looking statements contained herein. Big undertakes no obligation to update or revise (publicly or otherwise) any forward-looking statement, whether as a result of new information, future events or other circumstances. 2
Page 3
Mike Johns CFO/COO Charles Lewinton Acting CEO 3 Charles has over 20 years of experience in the electronic monitoring industry, with a strong focus on developing innovative software and hardware solutions. With a background in large-scale, secure software development, delivering innovative combinations of software and smart hardware to reduce operational costs. Mike is a qualified chartered accountant who trained with the accountancy firm RSM. He has held senior finance roles across several listed companies, most recently at Aptitude Software Group plc, where he spent seven years and was appointed CFO and Director in 2023 before joining Big Technologies plc in 2025.
Page 4
Introduction 4 150+ Customers Over 16 Countries 160+ staff Over 4 Countries High 60%+ Margin GPS/RF/Alcohol Solutions SaaS style Recurring Revenues Leaders in R&D for Electronic Monitoring Known for High- Quality Products Highly Cash Generative
Page 5
H1 Update £53.2m ARR (+5%) 66.7% gross margin £9.6m Adj. Free Cash Flow • New national contract in Chile (7 years, c $26m) • New national contract in Peru (2 years, c $600k) • Continued momentum in USA with wins in Westchester New York, California, Ohio, and Indiana. Statewide contract renewal in Tennessee. • Guatemala renewed for further 3 years • Release of AlcoBreath solution with 100+ active units • Inbound litigation settled in Q1 5 £14.2m Adj. EBITDA (+14%)
Page 6
Financial Review
Page 7
Financial Highlights ARR £53.2m Revenue £26.9m Adj. EBITDA £14.2m Annual Recurring Revenue (“ARR”) of £53.2m at 30 June 2026 (2025 c/c: £50.9m), growth of 5% • High revenue visibility derived from long term contracts • New contracts already won expected to generate over £2m of ARR in future periods Revenue of £26.9m (2025 c/c: £25.4m), growth of 6% • Revenue growth driven by new business wins in 2025 coming online in the first half • Strong contract momentum supports continued growth into 2027 Adjusted EBITDA of £14.2m in 2026 (2025: £12.5m), margin of 53% (2024: 49%) • Improving EBITDA margins driven by disciplined cost control and cost neutral investment approach to date • Selective investment in the US expected to drive further growth Adjusted free cash flow of £9.6m (2025: £6.7m), cash of £67.1m (2025: £96.7m) • Strong underlying cash generation driven by improvement in receivables discipline and process • Robust cash position at period end provides stability and acquisition flexibility 7 Adj. FCF £9.6m Cash £67.1m
Page 8
Financial Outlook Top 10 ARR 79% Gross Margin 66.7% Customer concentration: Top 10 clients 79% of ARR (2025: 77%) • Targeting reduction in customer concentration through US expansion • Largest customers not up for retender until 2028 Robust base: Net Retention Rate (“NRR”) of 98% (2025: 102%) • Client base happy and loyal to Buddi • Key churn outside of the Group’s control, with an immigration scheme terminated by legal challenge Competitive pricing approach: Gross Margin of 66.7% in 2025 (2025: 67.5%) • Full-service Northern Ireland contract impacts margins vs H 1 2025 • Planned reduction in gross margin in line with the Group ’s commercial approach on pricing 2026 marginally ahead of market consensus • Strong first half and trading since the year end resulting in improving performance versus consensus for 2026 NRR 98% 8
Page 9
Dec 2022 Dec 2023 Dec 2024 Dec 2025 Dec 2026 Dec 2027 Dec 2028 Dec 2029 Dec 2030 Dec 2031 Dec 2033 Dec 2032 Contracted Possible Extension Pre Tender Contract A - £12.3m (ARR at 30/6/26) Dec 2021 Contract B - £11.4m Contract C - £6.4m Contract D - £3.1m Contract E - £2.7m (expected on revenue commencement) Contract F - £2.0m Contract G - £1.7m Contract H - £1.7m Contract I - £1.3m Contract J - £1.0m 9 Contract Visibility Long term recurring revenue provides strong forward visibility
Page 10
Business Review
Page 11
Business Review – Contract Momentum Americas • Continued expansion in America with wins in Westchester, 3 further wins in California, Ohio and Indiana • 2-year state contract in Peru awarded (competitor take away) • 3-year extension to existing Guatemala contract following re-tender • Chile contract deployment in progress EMEA • Implementations in Latvia, Lithuania and Greece • Expansion of Swiss contract into 2 further Cantons APAC • Very stable contracts, working closely with customers on securing all renewals • Positive engagements with New Zealand on planned renewal 11
Page 12
New Products • Handheld breathalyser with tracking, GSM communication, AI facial recognition and 2- way voice • Orders for over 400 units in the US • ~50% size and weight of competitor products • Significant update to current AlcoTag to reduce the size by 50% • Increase battery life and increased sensitivity • Enhanced body detection • Silent operation • Daily use of AI by customers is already saving customers time and money • Next version of Eagle to include multiple new AI features AlcoTag v2.0 AlcoBreath Eagle AI 12
Page 13
<1 opportunity per year Worldwide £1m+ each 1-10 opportunities per year Worldwide £500k+ each 50+ opportunities per year Mainly USA £50k - £2m each Go To Market Strategies 13 Direct Sales Partnerships • Working with service providers to be their “tech partner” • Opens very large opportunities not available directly • Infrequent and slow turnarounds Full Service • Working on smaller scale contracts providing entire end to service • Lower margin as often 2/3 people 1/3 tech • Direct selling to governments and VARs • Quick turnaround as most do not require full tender • Competitive on price
Page 14
0 5 10 15 20 25 30 35 40 45 Months Equipment Revenue Example 14 Capital investment ranges from £150 - £600 Break even dependent on daily rates Profitability Month 0 Capital investment Month 3 Lease starts Product deployed and revenue commences Damaged or replaced
Page 15
R E T U R N T O G R O W T H Return to growth for first half of 2026 following a steam of new wins, providing an ARR growth of 5%. US growth continues at pace with multiple new wins in the first half of 2026, and a healthy pipeline of opportunities. Retention of existing contracts has remained extremely high, including Guatemala where a 3-year renewal was awarded. The Board expects the Group’s performance in 2026 will be in line with market expectations and that new contracts won will deliver further growth in 2027 and beyond. I N N O VA T I O N A T T H E C O R E Innovation remains at the core of Buddi with rapid technology updates, new products and future innovation planned. The Buddi products are known for being reliable, accurate, lightweight and simple to use. This USP remains strong in the brand worldwide Maintain competitive edge in R&D Partnership led approach Enhancing operational capacity Summary & Outlook 15
Page 16
Appendix
Page 17
Total Addressable Market 17 [40k] 4% Total MarketBig Technologies 583k US daily users 232k GPS daily users 60k Transdermal daily users [5.8k] 1% [20k] 8% [3k] 5% Market Penetration in specific markets 853K Worldwide daily users Total Addressable Market Big Technologies
Page 18
19 Years of innovation and new contracts 2008 Buddi V1 2009 2014 2016 2019 2020 Smart Tag v4 Connect SMART award for innovation 2010 Smart Tag & Buddi v2 2015 Smart Tag v2 Buddi clip 2017 nujjer 2020 NHS mental health pilot AUD$200m contract with NSW Australia Contract with US Intel-GE Care MoJ Covid contract 2021 Signed NZ DoC 2024 Smart Tag v5 & AlcoTag Border Control AlcoBreath 2023 2025 Northern Ireland 18 2026 AlcoTag V2 2027 Chile
Page 19
Feature Buddi (UK) Allied Universal (US) SuperCom (Israel) Enigma (Poland) Geosatis (Switzerland) BI (US) Sentinel (Allied Universal) (US) STOP (US) AMS (US) Track Group (US) Transdermal Alcohol (only real- time) (legacy) Breath Alcohol RF GPS Wrist-worn Victim Products (multiple) (mobile app) (mobile app) (mobile app) (mobile app) (mobile app) US/Latam (US only) (limited) (US only) (US only) (US only) (US only) EU (limited) APAC (limited) Size / Weight Smallest Small Medium Medium Large Large Medium Large Large Very Large Unique Features Shielding detection Quick fit strap GPS+Alcohol Smallest Cuff design Steel strap Price Competitive Competitive Cheap Cheap Expensive Competitive Competitive Cheap Expensive Competitive 19 Competitor Analysis
Page 20
• Full range of products including tracking, alcohol and victim all integrated into a single cloud-based software system • Designed to be small and lightweight to increase wearer compliance • Intelligent firmware which creates market leading battery life, improved communications coverage, reducing alerts resulting in significant savings in monitoring costs • Multiple unique features including dual roaming SIMs, shielding detection, Wi-Fi communications, body sensing, facial and fingerprint biometrics • High quality end-to-end design and manufacturing Victim SolutionsTracking Solutions Curfew Solutions Alcohol Solutions Technical Advantage 20
Page 21
Profit and Loss 21 H1 2026 £’000 H1 2025 £’000 FY 2025 £’000 Revenue 26,922 24,796 49,727 Cost of sales (8,962) (8,059) (16,874) Gross profit 17,960 16,737 32,853 Gross Profit Margin 66.7% 67.5% 66.1% Administrative expenses (ex. non-underlying items) (6,518) (7,218) (14,323) Adjusted operating profit 11,442 9,519 18,530 Adjusted operating profit margin 42.5% 38.4% 37% Non-underlying items (2,346) (36,655) (41,545) Statutory operating profit/(loss) 9,096 (27,136) (23,015) Net interest 411 1,425 2,530 Profit/(loss) before tax 9,507 (25,711) (20,485) Taxation (1,812) (3,166) (2,700) Profit/(loss) for the year 7,695 (28,877) (23,185) Adjusted EBITDA 14,182 12,508 24,600 Adjusted EBITDA margin 52.7% 50% 49%
Page 22
Balance Sheet 22 30 June 2026 £’000 30 June 2025 £’000 31 Dec 2025 £’000 Goodwill and intangible assets 17,669 18,034 17,824 Property, plant and equipment and right of use assets 6,396 6,593 6,589 Other non-current assets 2,345 1,814 2,345 Total non-current assets 26,410 26,441 26,758 Inventories 6,575 7,272 7,136 Trade and other receivables 15,972 8,716 16,932 Cash 67,083 96,699 93,367 Total current assets 89,630 112,687 117,435 Total assets 116,040 139,128 144,193 Provision 1,130 42,650 39,695 Other current liabilities 13,230 8,491 10,197 Total current liabilities 14,360 51,141 49,892 Total non-current liabilities 2,726 2,547 3,009 Net current assets 75,270 61,546 67,543 Net assets 98,954 85,440 91,292
Page 23
Cash Flow 23 H1 2026 £’000 H1 2025 £’000 FY 2025 £’000 Cash generated from operations (excluding settlement payment) 11,721 7,368 10,182 Settlement payment (33,444) - - Cash (used in) / generated from operations (21,623) 7,368 10,182 Taxes paid (2,555) (1,985) (6,426) Cash (used in) / generated from operating activities (24,178) 5,383 3,756 Own work capitalised (1,969) (1,946) (3,804) Capitalised development costs (525) (566) (1,218) Interest received 481 1,488 2,626 Other investing activities (48) (192) (303) Cash used in investing activities (2,061) (1,216) (2,699) Purchase of shares (EBT/buyback scheme) - (2,994) (2,994) Other financing activities (228) (161) (396) Cash used in financing activities (228) (3,155) (3,390) (Decrease)/Increase in cash (26,468) 1,012 (2,333) Exchange rate losses on cash and cash equivalents 183 (43) (30) Cash and cash equivalents at end of period 67,083 96,699 93,367